Abstract
Though many therapies exist for alopecia areata, one of the most unique is topical sensitization. By altering the pathogenic inflammatory response with few side effects, sensitizers offer an attractive treatment option for many patients with alopecia areata, including those who have previously failed more traditional treatments and those who have extensive disease.
MeSH terms
-
Adjuvants, Immunologic / therapeutic use*
-
Administration, Cutaneous
-
Alopecia Areata / drug therapy*
-
Alopecia Areata / immunology
-
Cyclobutanes / therapeutic use
-
Cyclopropanes / immunology
-
Cyclopropanes / therapeutic use
-
Dinitrochlorobenzene / therapeutic use
-
Humans
-
Inflammation
-
Irritants / immunology
-
Irritants / therapeutic use*
-
Patient Selection
-
Prognosis
-
Severity of Illness Index
-
Treatment Outcome
Substances
-
Adjuvants, Immunologic
-
Cyclobutanes
-
Cyclopropanes
-
Dinitrochlorobenzene
-
Irritants
-
squaric acid dibutyl ester
-
diphenylcyclopropenone